BRIEF-Cassava Sciences Inc - informed by JPAD that there is no convincing evidence to support allegations of data manipulation in a 2020 paper

Reuters2022-08-18

Aug 18 (Reuters) - Cassava Sciences Inc :

* CASSAVA SCIENCES INC - INFORMED BY JPAD THAT THERE IS NO CONVINCING EVIDENCE TO SUPPORT ALLEGATIONS OF DATA MANIPULATION IN A 2020 PAPER

Source text for Eikon: Further company coverage:

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

alicat
2022-08-19
alicat
does anybody know tony
alicat
2022-08-19
alicat
الوو انتم تمام

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2260339331?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-08-18 21:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2260339331","market":"us","top_or_hot":-1,"title":"BRIEF-Cassava Sciences Inc - informed by JPAD that there is no convincing evidence to support allegations of data manipulation in a 2020 paper","media":"Reuters","content":"<html><body><p>Aug 18 (Reuters) - <a href=\"https://laohu8.com/S/SAVA\">Cassava Sciences Inc</a>   :</p><p>   * CASSAVA SCIENCES INC - INFORMED BY JPAD THAT THERE IS NO CONVINCING EVIDENCE TO SUPPORT ALLEGATIONS OF DATA MANIPULATION IN A 2020 PAPER</p><p>Source text for Eikon:    Further company coverage:   </p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Cassava Sciences Inc - informed by JPAD that there is no convincing evidence to support allegations of data manipulation in a 2020 paper</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Cassava Sciences Inc - informed by JPAD that there is no convincing evidence to support allegations of data manipulation in a 2020 paper\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-08-18 21:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Aug 18 (Reuters) - <a href=\"https://laohu8.com/S/SAVA\">Cassava Sciences Inc</a>   :</p><p>   * CASSAVA SCIENCES INC - INFORMED BY JPAD THAT THERE IS NO CONVINCING EVIDENCE TO SUPPORT ALLEGATIONS OF DATA MANIPULATION IN A 2020 PAPER</p><p>Source text for Eikon:    Further company coverage:   </p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4196","symbol_name":"保健护理服务","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2260339331","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2260339331","pubTimestamp":1660828664,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Aug 18 (Reuters) - Cassava Sciences Inc   :   * CASSAVA SCIENCES INC - INFORMED BY JPAD THAT THERE I","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4196":"保健护理服务","BK4023":"应用软件","BK4547":"WSB热门概念","ONTF":"ON24, Inc.","SAVA":"Cassava Sciences Inc","BK4139":"生物科技","BK4082":"医疗保健设备","CGEM":"Cullinan Therapeutics","LABP":"Landos Biopharma, Inc.","SANA":"Sana Biotechnology, Inc.","BK4007":"制药","LHDX":"Lucira Health, Inc."},"translate_title":"JPAD告知木薯科学公司，没有令人信服的证据支持2020年一篇论文中数据操纵的指控","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SANA":1,"ONTF":1,"APR":1,"SAVA":1,"LHDX":1,"LABP":1,"CGEM":1},"content_text":"Aug 18 (Reuters) - Cassava Sciences Inc   :   * CASSAVA SCIENCES INC - INFORMED BY JPAD THAT THERE IS NO CONVINCING EVIDENCE TO SUPPORT ALLEGATIONS OF DATA MANIPULATION IN A 2020 PAPERSource text for Eikon:    Further company coverage:","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[{"id":9991426329,"gmtCreate":1660872115863,"gmtModify":1676536415394,"author":{"id":"4118255547339272","authorId":"4118255547339272","name":"alicat","avatar":"https://community-static.tradeup.com/news/d1bfaaa1d393f325414e289e2a2a8951","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4118255547339272","authorIdStr":"4118255547339272"},"htmlText":"does anybody know tony&nbsp;","listText":"does anybody know tony&nbsp;","text":"does anybody know tony","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9991426329","repostId":2260339331,"repostType":2,"repost":{"id":"2260339331","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1660828664,"share":"https://ttm.financial/m/news/2260339331?lang=en_US&edition=fundamental","pubTime":"2022-08-18 21:17","market":"us","language":"en","title":"BRIEF-Cassava Sciences Inc - informed by JPAD that there is no convincing evidence to support allegations of data manipulation in a 2020 paper","url":"https://stock-news.laohu8.com/highlight/detail?id=2260339331","media":"Reuters","summary":"Aug 18 (Reuters) - Cassava Sciences Inc   :   * CASSAVA SCIENCES INC - INFORMED BY JPAD THAT THERE I","content":"<html><body><p>Aug 18 (Reuters) - <a href=\"https://laohu8.com/S/SAVA\">Cassava Sciences Inc</a>   :</p><p>   * CASSAVA SCIENCES INC - INFORMED BY JPAD THAT THERE IS NO CONVINCING EVIDENCE TO SUPPORT ALLEGATIONS OF DATA MANIPULATION IN A 2020 PAPER</p><p>Source text for Eikon:    Further company coverage:   </p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Cassava Sciences Inc - informed by JPAD that there is no convincing evidence to support allegations of data manipulation in a 2020 paper</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Cassava Sciences Inc - informed by JPAD that there is no convincing evidence to support allegations of data manipulation in a 2020 paper\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-08-18 21:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Aug 18 (Reuters) - <a href=\"https://laohu8.com/S/SAVA\">Cassava Sciences Inc</a>   :</p><p>   * CASSAVA SCIENCES INC - INFORMED BY JPAD THAT THERE IS NO CONVINCING EVIDENCE TO SUPPORT ALLEGATIONS OF DATA MANIPULATION IN A 2020 PAPER</p><p>Source text for Eikon:    Further company coverage:   </p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4196":"保健护理服务","BK4023":"应用软件","BK4547":"WSB热门概念","ONTF":"ON24, Inc.","SAVA":"Cassava Sciences Inc","BK4139":"生物科技","BK4082":"医疗保健设备","CGEM":"Cullinan Therapeutics","LABP":"Landos Biopharma, Inc.","SANA":"Sana Biotechnology, Inc.","BK4007":"制药","LHDX":"Lucira Health, Inc."},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2260339331","content_text":"Aug 18 (Reuters) - Cassava Sciences Inc   :   * CASSAVA SCIENCES INC - INFORMED BY JPAD THAT THERE IS NO CONVINCING EVIDENCE TO SUPPORT ALLEGATIONS OF DATA MANIPULATION IN A 2020 PAPERSource text for Eikon:    Further company coverage:","news_type":1,"symbols_score_info":{"SANA":1,"ONTF":1,"APR":1,"SAVA":1,"LHDX":1,"LABP":1,"CGEM":1}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9991428734,"gmtCreate":1660872103630,"gmtModify":1676536415386,"author":{"id":"4118255547339272","authorId":"4118255547339272","name":"alicat","avatar":"https://community-static.tradeup.com/news/d1bfaaa1d393f325414e289e2a2a8951","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4118255547339272","authorIdStr":"4118255547339272"},"htmlText":"الوو انتم تمام&nbsp;","listText":"الوو انتم تمام&nbsp;","text":"الوو انتم تمام","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9991428734","repostId":2260339331,"repostType":2,"repost":{"id":"2260339331","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1660828664,"share":"https://ttm.financial/m/news/2260339331?lang=en_US&edition=fundamental","pubTime":"2022-08-18 21:17","market":"us","language":"en","title":"BRIEF-Cassava Sciences Inc - informed by JPAD that there is no convincing evidence to support allegations of data manipulation in a 2020 paper","url":"https://stock-news.laohu8.com/highlight/detail?id=2260339331","media":"Reuters","summary":"Aug 18 (Reuters) - Cassava Sciences Inc   :   * CASSAVA SCIENCES INC - INFORMED BY JPAD THAT THERE I","content":"<html><body><p>Aug 18 (Reuters) - <a href=\"https://laohu8.com/S/SAVA\">Cassava Sciences Inc</a>   :</p><p>   * CASSAVA SCIENCES INC - INFORMED BY JPAD THAT THERE IS NO CONVINCING EVIDENCE TO SUPPORT ALLEGATIONS OF DATA MANIPULATION IN A 2020 PAPER</p><p>Source text for Eikon:    Further company coverage:   </p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Cassava Sciences Inc - informed by JPAD that there is no convincing evidence to support allegations of data manipulation in a 2020 paper</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Cassava Sciences Inc - informed by JPAD that there is no convincing evidence to support allegations of data manipulation in a 2020 paper\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-08-18 21:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Aug 18 (Reuters) - <a href=\"https://laohu8.com/S/SAVA\">Cassava Sciences Inc</a>   :</p><p>   * CASSAVA SCIENCES INC - INFORMED BY JPAD THAT THERE IS NO CONVINCING EVIDENCE TO SUPPORT ALLEGATIONS OF DATA MANIPULATION IN A 2020 PAPER</p><p>Source text for Eikon:    Further company coverage:   </p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4196":"保健护理服务","BK4023":"应用软件","BK4547":"WSB热门概念","ONTF":"ON24, Inc.","SAVA":"Cassava Sciences Inc","BK4139":"生物科技","BK4082":"医疗保健设备","CGEM":"Cullinan Therapeutics","LABP":"Landos Biopharma, Inc.","SANA":"Sana Biotechnology, Inc.","BK4007":"制药","LHDX":"Lucira Health, Inc."},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2260339331","content_text":"Aug 18 (Reuters) - Cassava Sciences Inc   :   * CASSAVA SCIENCES INC - INFORMED BY JPAD THAT THERE IS NO CONVINCING EVIDENCE TO SUPPORT ALLEGATIONS OF DATA MANIPULATION IN A 2020 PAPERSource text for Eikon:    Further company coverage:","news_type":1,"symbols_score_info":{"SANA":1,"ONTF":1,"APR":1,"SAVA":1,"LHDX":1,"LABP":1,"CGEM":1}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":0,"commentSize":2,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2260339331","isCrawlerRequest":true}